Bart Barlogie: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

1

The pattern of Mesenchymal stem cell expression is an independent marker of outcome in multiple myeloma.

Schinke, Carolina, Qu, Pingping, Mehdi, Syed J, Hoering, Antje, Epstein, Joshua, Johnson, Sarah, van Rhee, Frits, Zangari, Maurizio, Thanendrarajan, Sharmilan, Barlogie, Bart, Davies, Faith E, Yaccoby

Journal:

Clinical Cancer Research

Year:

2018

Language:

english

File:

PDF, 9.26 MB

english, 2018

2

Cytogenetic abnormalities in multiple myeloma: poor prognosis linked to concomitant detection in random and focal lesion bone marrow samples and associated with high-risk gene expression profile

Yiming Zhou, Bijay Nair, John D Shaughnessy Jr, Marie-Astrid Cartron, Jeff Haessler, Elias Anaissie, Frits Van Rhee, John Crowley, Bart Barlogie

Journal:

British Journal of Haematology

Year:

2009

Language:

english

File:

PDF, 323 KB

english, 2009

3

Complete remission sustained 3 years from treatment initiation is a powerful surrogate for extended survival in multiple myeloma

Bart Barlogie, Elias Anaissie, Jeffrey Haessler, Fritz van Rhee, Mauricio Pineda-Roman, Klaus Hollmig, Yazan Alsayed, Joshua Epstein, John D. Shaughnessy Jr, John Crowley

Journal:

Year:

2008

Language:

english

File:

PDF, 387 KB

english, 2008

4

Extended follow-up of a phase II trial in relapsed, refractory multiple myeloma: : Final time-to-event results from the SUMMIT trial

Paul G. Richardson, Bart Barlogie, James Berenson, Seema Singhal, Sundar Jagannath, David H. Irwin, S. Vincent Rajkumar, Gordan Srkalovic, Melissa Alsina, Kenneth C. Anderson

Journal:

Year:

2006

Language:

english

File:

PDF, 123 KB

english, 2006

5

New Insights into the Molecular Basis of Multiple Myeloma Pathogenesis and Prognosis

Shaughnessy, John D., Barlogie, Bart

Journal:

Clinical Lymphoma & Myeloma

Year:

2009

Language:

english

File:

PDF, 87 KB

english, 2009

6

Morphologic Heterogeneity of Renal Light-Chain Deposition Disease

Gokden, Neriman, Barlogie, Bart, Liapis, Helen

Journal:

Ultrastructural Pathology

Year:

2008

Language:

english

File:

PDF, 437 KB

english, 2008

7

A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma

Richardson, Paul G., Barlogie, Bart, Berenson, James, Singhal, Seema, Jagannath, Sundar, Irwin, David, Rajkumar, S. Vincent, Srkalovic, Gordan, Alsina, Melissa, Alexanian, Raymond, Siegel, David, Orlo

Journal:

Boston Medical and Surgical Journal

Year:

2003

Language:

english

File:

PDF, 134 KB

english, 2003

8

Paradoxical expression of INK4c in proliferative multiple myeloma tumors: bi-allelic deletion vs increased expression

Amel Dib, Timothy R Peterson, Laura Raducha-Grace, Adriana Zingone, Fenghuang Zhan, Ichiro Hanamura, Bart Barlogie, John Shaughnessy, W Michael Kuehl

Journal:

Year:

2006

Language:

english

File:

PDF, 512 KB

english, 2006

9

Prognostic factors in multiple myeloma: The M.D. Anderson experience

Bart Barlogie, Raymond Alexanian

Journal:

European Journal of Haematology

Year:

1989

Language:

english

File:

PDF, 213 KB

english, 1989

10

Thalidomide in hematologic malignancies: Future directions

Raymond Alexanian, Kenneth C Anderson, Bart Barlogie, David I Stirling, Deborah A Thomas

Journal:

Seminars in Hematology

Year:

2000

Language:

english

File:

PDF, 507 KB

english, 2000

11

Epigenetic modulation of MAGE-A3 antigen expression in multiple myeloma following treatment with the demethylation agent 5-azacitidine and the histone deacetlyase inhibitor MGCD0103

Moreno-Bost, Amberly, Szmania, Susann, Stone, Katie, Garg, Tarun, Hoerring, Antje, Szymonifka, Jackie, Shaughnessy, John, Barlogie, Bart, Grant Prentice, H., van Rhee, Frits

Journal:

Year:

2011

Language:

english

File:

PDF, 305 KB

english, 2011

12

Hematopoietic Stem Cell Autografts in Support of Myeloablative Therapy for Multiple Myeloma*

BARLOGIE, BART, JAGANNATH, SUNDAR, VESOLE, DAVID, TRICOT, GUIDO

Journal:

Journal of Hematotherapy

Year:

1994

Language:

english

File:

PDF, 664 KB

english, 1994

13

High-risk myeloma is associated with global elevation of miRNAs and overexpression of EIF2C2/AGO2

Zhou, Yiming, Chen, Lijuan, Barlogie, Bart, Stephens, Owen, Wu, Xiaosong, Williams, David R., Cartron, Marie-Astrid, van Rhee, Frits, Nair, Bijay, Waheed, Sarah, Pineda-Roman, Mauricio, Alsayed, Yazan

Journal:

Proceedings of the National Academy of Sciences

Year:

2010

Language:

english

File:

PDF, 429 KB

english, 2010

14

Hematopoietic Stem Cell Transplants for Multiple Myeloma

Tricot, Guido, Jagannath, Sundar, Vesole, David H., Bracy, Dwayne, Desikan, K. R., Siegel, David, Barlogie, Bart

Journal:

Leukemia and Lymphoma

Year:

1996

Language:

english

File:

PDF, 1.24 MB

english, 1996

15

Characterization of the Molecular Mechanism of the Bone-Anabolic Activity of Carfilzomib in Multiple Myeloma

Hu, Bo, Chen, Yu, Usmani, Saad Z., Ye, Shiqiao, Qiang, Wei, Papanikolaou, Xenofon, Heuck, Christoph J., Yaccoby, Shmuel, Williams, Bart O., Van Rhee, Frits, Barlogie, Bart, Epstein, Joshua, Qiang, Ya-

Journal:

Year:

2013

Language:

english

File:

PDF, 2.99 MB

english, 2013

16

Gene Expression Profiling Reveals Aberrant T-cell Marker Expression on Tumor Cells of Waldenström's Macroglobulinemia

Hao, Mu, Barlogie, Bart, Tricot, Guido, Liu, Lanting, Qiu, Luqui, Shaughnessy, John D., Zhan, Fenghuang

Journal:

Clinical Cancer Research

Year:

2018

Language:

english

File:

PDF, 1.30 MB

english, 2018

17

Risk stratification of smoldering multiple myeloma: predictive value of free light chains and group-based trajectory modeling

Wu, Vernon, Moshier, Erin, Leng, Siyang, Barlogie, Bart, Cho, Hearn Jay, Jagannath, Sundar, Madduri, Deepu, Mazumdar, Madhu, Parekh, Samir, Chari, Ajai

Journal:

Year:

2018

File:

PDF, 1011 KB

2018

18

Increased Muscle CXCR4 Expression in the Setting of Rare Muscle-invasive Multiple Myeloma

Mouhieddine, Tarek H., Ahmad, Yasir, Barlogie, Bart, Jagannath, Sundar, Teruya-Feldstein, Julie, Richter, Joshua

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2020

File:

PDF, 972 KB

2020

19

Phase II trial of echinomycin for the treatment of advanced renal cell carcinoma

M. Ernest Marshall, Michael K. Wolf, E. David Crawford, Sarah Taylor, Brent Blumenstein, Robert Flanigan, Fredrick J. Meyers, Harry E. Hynes, Bart Barlogie, Mario Eisenberger

Journal:

Investigational New Drugs

Year:

1993

Language:

english

File:

PDF, 185 KB

english, 1993

20

Waldenström’s macroglobulinemia

K. Raman Desikan, Madhav V. Dhodapkar, Bart Barlogie

Journal:

Current Treatment Options in Oncology

Year:

2000

Language:

english

File:

PDF, 272 KB

english, 2000

21

Inhibitor of DASH proteases affects expression of adhesion molecules in osteoclasts and reduces myeloma growth and bone disease

Angela Pennisi, Xin Li, Wen Ling, Sharmin Khan, Dana Gaddy, Larry J. Suva, Bart Barlogie, John D. Shaughnessy, Nazneen Aziz, Shmuel Yaccoby

Journal:

British Journal of Haematology

Year:

2009

Language:

english

File:

PDF, 450 KB

english, 2009

22

Prognostic factors and response to fludarabine therapy in Waldenstrom's macroglobulinemia: An update of a US intergroup trial (SW0G S9003)

Madhav V. Dhodapkar, Joth L. Jacobson, Morie A. Gertz, John J. Crowley, Bart Barlogie

Journal:

Seminars in Oncology

Year:

2003

Language:

english

File:

PDF, 91 KB

english, 2003

23

US Cooperative Group Trials

Lonial, Sagar, Giralt, Sergio, Durie, Brian, Barlogie, Bart, Stadtmauer, Edward, Anderson, Kenneth C., Rajkumar, S. Vincent

Journal:

Clinical Lymphoma & Myeloma

Year:

2009

Language:

english

File:

PDF, 92 KB

english, 2009

24

Superior 12-Year Survival After at Least 4-Year Continuous Remission with Tandem Transplantations for Multiple Myeloma

Barlogie, Bart, Zangari, Maurizio, Bolejack, Vanessa, Hollmig, Klaus, Anaissie, Elias, van Rhee, Frits, Pineda-Roman, Mauricio, Mohiuddin, Abid, Crowley, John, Tricot, Guido

Journal:

Clinical Lymphoma & Myeloma

Year:

2006

Language:

english

File:

PDF, 156 KB

english, 2006

25

Use of Spleen as an Internal Marker in Whole Body DWIBS Exam in Patients of Multiple Myeloma

Kumar, Manoj, Samant, Rohan, Van Hemert, Rudy, Fitzgerald, Ryan, Singh, Zeba, Pandey, Soumya, Lensing, Shelly Y., Barlogie, Bart, Angtuaco, Edgardo

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2014

Language:

english

File:

PDF, 54 KB

english, 2014

26

Fulminant onset of acute leukemia from normal hematopoiesis within 3 months of follow up for multiple myeloma treated with total therapy protocols

Singh, Zeba N., Jethava, Yogesh, Post, Ginell R., Alapat, Daisy, Sawyer, Jeffrey, Waheed, Sarah, Nair, Bijay, Usmani, Saad Z., Bailey, Clyde, Petty, Nathan, Van Rhee, Frits, Barlogie, Bart

Journal:

Clinical Case Reports

Year:

2015

Language:

english

File:

PDF, 1.30 MB

english, 2015

27

Disease and outcome disparities in multiple myeloma: exploring the role of race/ethnicity in the Cooperative Group clinical trials

Ailawadhi, Sikander, Jacobus, Susanna, Sexton, Rachael, Stewart, Alexander K., Dispenzieri, Angela, Hussein, Mohamad A., Zonder, Jeffrey A., Crowley, John, Hoering, Antje, Barlogie, Bart, Orlowski, Ro

Journal:

Blood Cancer Journal

Year:

2018

Language:

english

File:

PDF, 544 KB

english, 2018

28

[American Thoracic Society American Thoracic Society 2011 International Conference, May 13-18, 2011 â¢ Denver Colorado - ()] B43. DRUG INDUCED AND CONNECTIVE TISSUE RELATED LUNG DISORDERS - Effect Of High Dose Chemotherapy And Autologous Stem Cell Transplantation On Pulmonary Function In Multiple Myeloma

Siddiqui, Mohammad F., Badireddi, Sridhar, Anaissie, Elias, Barlogie, Bart, Hiller, Federick C.

Year:

2011

File:

PDF, 32 KB

2011

29

The Evaluation of Gemcitabine in Resistant or Relapsing Multiple Myeloma, Phase II: a Southwest Oncology Group Study

James K. Weick, John J. Crowley, Mohamed A. Hussein, Dennis F. Moore, Bart Barlogie

Journal:

Investigational New Drugs

Year:

2002

Language:

english

File:

PDF, 61 KB

english, 2002

30

Fludarabine therapy in Waldenström's macroglobulinemia

Meletios A. Dimopoulos, Susan O'Brien, Hagop Kantarjian, Sherry Pierce, Kay Delasalle, Bart Barlogie, Raymond Alexanian, Michael J. Keating

Journal:

The American Journal of Medicine

Year:

1993

Language:

english

File:

PDF, 502 KB

english, 1993

31

TRIM13 (RFP2) downregulation decreases tumour cell growth in multiple myeloma through inhibition of NF Kappa B pathway and proteasome activity

Gatt, Moshe E., Takada, Kohichi, Mani, Mala, Lerner, Mikael, Pick, Marjorie, Hideshima, Teru, Carrasco, Daniel E., Protopopov, Alexei, Ivanova, Elena, Sangfelt, Olle, Grandér, Dan, Barlogie, Bart, Sha

Journal:

British Journal of Haematology

Year:

2013

Language:

english

File:

PDF, 720 KB

english, 2013

32

Role of Bruton's tyrosine kinase in myeloma cell migration and induction of bone disease

Bam, Rakesh, Ling, Wen, Khan, Sharmin, Pennisi, Angela, Venkateshaiah, Sathisha Upparahalli, Li, Xin, van Rhee, Frits, Usmani, Saad, Barlogie, Bart, Shaughnessy, John, Epstein, Joshua, Yaccoby, Shmuel

Journal:

American Journal of Hematology

Year:

2013

Language:

english

File:

PDF, 1.78 MB

english, 2013

33

CYR61 / CCN1 overexpression in the myeloma microenvironment is associated with superior survival and reduced bone disease

Johnson, Sarah K, Stewart, James P, Bam, Rakesh, Qu, Pingping, Barlogie, Bart, Rhee, Frits Van, Jr, John D Shaughnessy, Epstein, Joshua, Yaccoby, Shmuel

Year:

2015

Language:

english

File:

PDF, 1.40 MB

english, 2015

34

High Serum Levels of Lactic Dehydrogenase Identify a High-Grade Lymphoma-like Myeloma

Journal:

Annals of Internal Medicine

Year:

1989

Language:

english

File:

PDF, 890 KB

english, 1989

35

Investigation of a gene signature to predict response to immunomodulatory derivatives for patients with multiple myeloma: an exploratory, retrospective study using microarray datasets from prospective clinical trials

Bhutani, Manisha, Zhang, Qing, Friend, Reed, Voorhees, Peter M, Druhan, Lawrence J, Barlogie, Bart, Sonneveld, Pieter, Morgan, Gareth J, Symanowski, James T, Avalos, Belinda R, Copelan, Edward A, Usma

Journal:

The Lancet Haematology

Year:

2017

Language:

english

File:

PDF, 412 KB

english, 2017

36

Bone marrow morphologic features, MyPRS, and gene mutation correlations in plasma cell myeloma

Hao, Yansheng, Khaykin, Daniel, Machado, Levi, van den Akker, Tayler, Houldsworth, Jane, Barlogie, Bart, Hussein, Shafinaz, El Jamal, Siraj M., Petersen, Bruce, Teruya-Feldstein, Julie

Journal:

Modern Pathology

Year:

2019

Language:

english

File:

PDF, 1.81 MB

english, 2019

37

New treatment strategies for multiple myeloma

Dr Raymond Alexanian, Bart Barlogie

Journal:

American Journal of Hematology

Year:

1990

Language:

english

File:

PDF, 520 KB

english, 1990

38

Prognostic impact of cytogenetic and interphase fluorescence in situ hybridization-defined chromosome 13 deletion in multiple myeloma: early results of total therapy II

John Shaughnessy Jr, Erming Tian, Jeffrey Sawyer, Jason McCoy, Guido Tricot, Joth Jacobson, Elias Anaissie, Maurizio Zangari, Athanasios Fassas, Firas Muwalla, Christopher Morris, Bart Barlogie

Journal:

British Journal of Haematology

Year:

2003

Language:

english

File:

PDF, 419 KB

english, 2003

39

Phase II study of carboplatin (CBDCA) in refractory multiple myeloma

Bart Barlogie, John Crowley, Sydney E. Salmon, John Bonnet, James K. Weick, Kathy Hayden

Journal:

Investigational New Drugs

Year:

1994

Language:

english

File:

PDF, 233 KB

english, 1994

40

Correlation of TACC3, FGFR3, MMSET and p21 expression with the t(4;14)(p16·3;q32) in multiple myeloma

James Peter Stewart, Alexander Thompson, Madhumita Santra, Bart Barlogie, Terence R. J. Lappin, John Shaughnessy Jr

Journal:

British Journal of Haematology

Year:

2004

Language:

english

File:

PDF, 202 KB

english, 2004

41

Immunoglobulin isotypes in multiple myeloma: laboratory correlates and prognostic implications in total therapy protocols

Bijay Nair, Sarah Waheed, Jackie Szymonifka, John D Shaughnessy Jr, John Crowley, Bart Barlogie

Journal:

British Journal of Haematology

Year:

2009

Language:

english

File:

PDF, 70 KB

english, 2009

42

The Arkansas approach to therapy of patients with multiple myeloma

Bart Barlogie, Elias Anaissie, Frits van Rhee, Mauricio Pineda-Roman, Maurizio Zangari, John Shaughnessy, Joshua Epstein, John Crowley

Journal:

Best Practice & Research Clinical Haematology

Year:

2007

Language:

english

File:

PDF, 1.30 MB

english, 2007

43

Recurrent Spontaneous Gastrointestinal Graft-Versus-Host Disease in Autologous Hematopoietic Stem Cell Transplantation

Somashekar G. Krishna, Bart Barlogie, Laura W. Lamps, Kavya Krishna, Farshad Aduli, Elias Anaissie

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2010

Language:

english

File:

PDF, 650 KB

english, 2010

44

Immunization With a Recombinant MAGE-A3 Protein After High-dose Therapy for Myeloma

Szmania, Susann, Gnjatic, Sacha, Tricot, Guido, Stone, Katie, Zhan, Fenghuang, Moreno, Amberly, Thuro, Brad, Melenhorst, Jos, Barrett, John, Shaughnessy, John, Old, Lloyd J., Barlogie, Bart, Brichard,

Journal:

Journal of Immunotherapy

Year:

2007

Language:

english

File:

PDF, 252 KB

english, 2007

45

Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma — an IMWG Research Project

Usmani, Saad Z., Hoering, Antje, Cavo, Michele, Miguel, Jesus San, Goldschimdt, Hartmut, Hajek, Roman, Turesson, Ingemar, Lahuerta, Juan Jose, Attal, Michel, Barlogie, Bart, Lee, Jae Hoon, Kumar, Shaj

Journal:

Blood Cancer Journal

Year:

2018

Language:

english

File:

PDF, 660 KB

english, 2018

46

Hepatitis B reactivation in patients with multiple myeloma and isolated positive hepatitis B core antibody: a call for greater cognizance

Yang, Ju Dong, Girotra, Mohit, Restrepo, Alejandro, Waheed, Sarah, Barlogie, Bart, Duarte-Rojo, Andres

Journal:

Annals of Hepatology

Year:

2014

Language:

english

File:

PDF, 158 KB

english, 2014

47

Myeloma-reactive allospecific cytotoxic T lymphocytes lyse target cells via the granule exocytosis pathway

Maurizio Chiriva-Internati, Jianhui Du, Martin Cannon, Bart Barlogie, Qing Yi

Journal:

British Journal of Haematology

Year:

2001

Language:

english

File:

PDF, 403 KB

english, 2001

48

Mobilization of CD34+ cells in elderly patients (≥ 70 years) with multiple myeloma: influence of age, prior therapy, platelet count and mobilization regimen

Christopher L. Morris, Eric Siegel, Bart Barlogie, Michele Cottler-Fox, Pei Lin, Athanasios Fassas, Maurizio Zangari, Elias Anaissie, Guido Tricot

Journal:

British Journal of Haematology

Year:

2003

Language:

english

File:

PDF, 320 KB

english, 2003

49

Biclonal and hypodiploid multiple myeloma

Lon Smith, Bart Barlogie, Raymond Alexanian

Journal:

The American Journal of Medicine

Year:

1986

Language:

english

File:

PDF, 283 KB

english, 1986

50

The use of molecular-based risk stratification and pharmacogenomics for outcome prediction and personalized therapeutic management of multiple myeloma

Sarah K. Johnson, Christoph J. Heuck, Anthony P. Albino, Pingping Qu, Qing Zhang, Bart Barlogie, John D. Shaughnessy

Journal:

International Journal of Hematology

Year:

2011

Language:

english

File:

PDF, 1.85 MB

english, 2011

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@1delivery.pm

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски